GLENMARK - Swing Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Swing Trade Rating: 4.1

GLENMARK shows strong short-term momentum, positive financials, and continued earnings growth, making it a solid candidate for a momentum-based swing trade. However, valuation metrics suggest it’s already pricey, and momentum indicators are nearing exhaustion — tactical entry is key here.

📈 Fundamental Snapshot

Valuation

P/E: 46.3 vs Industry PE: 34.0 → Premium-priced, but justifiable with growth

PEG Ratio: 7.41 → Expensive in growth-adjusted terms

EPS: ₹37.1, Book Value: ₹314 → Strong underlying value

Profitability

ROCE: 19.4%, ROE: 15.8% → Above industry benchmarks

PAT Qtr: ₹370 Cr. vs ₹348 Cr. → Consistent growth, Qtr Var: 116%

Debt Profile

Debt-to-Equity: 0.28 → Reasonable leverage

Institutional Movement

FII Hold ↓ 2.53%, DII Hold ↑ 3.04% → Shift towards domestic conviction

📊 Technical Overview

Price Action

Current Price ₹2,158 is well above

DMA 50: ₹1,850

DMA 200: ₹1,576 → Strong bullish momentum

Momentum

RSI: 73.2 → Approaching overbought territory, risk of cooldown

MACD: 119 → Strong bullish crossover

Volume: 10.9L vs 11.4L (Avg) → Holding firm, slight tapering

52W Index: 87.3% → Closing in on yearly high of ₹2,286

🧭 Swing Strategy Setup

✅ Optimal Entry (New Position)

Entry Price: ₹2,080–₹2,120 Wait for a minor pullback from overbought zone to improve entry risk.

Ideal entry is near 10–15% above 50-DMA, with RSI dipping to 65–68.

🚪 Exit Strategy

Target Price: ₹2,250–₹2,280 Right below 52-week high — aim to lock profits before overhead resistance.

Stop-Loss: ₹1,990 Below recent breakout zone.

📌 If Already Holding

Consider holding with a trailing stop if price moves toward ₹2,250+

Monitor MACD for flattening and RSI for reversal signs above 75

If volume drops while RSI stays elevated, take partial profits

Would you like me to screen comparable pharmaceutical stocks with better PEG ratios and RSI cooling off? Could open up some fresher setups.

Edit in a page